BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24163811)

  • 1. Pre- and postsynaptic dopamine SPECT in idiopathic Parkinsonian diseases: a follow-up study.
    Jakobson Mo S; Linder J; Forsgren L; Holmberg H; Larsson A; Riklund K
    Biomed Res Int; 2013; 2013():143532. PubMed ID: 24163811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.
    Kim YJ; Ichise M; Ballinger JR; Vines D; Erami SS; Tatschida T; Lang AE
    Mov Disord; 2002 Mar; 17(2):303-12. PubMed ID: 11921116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients.
    Plotkin M; Amthauer H; Klaffke S; Kühn A; Lüdemann L; Arnold G; Wernecke KD; Kupsch A; Felix R; Venz S
    J Neural Transm (Vienna); 2005 May; 112(5):677-92. PubMed ID: 15375677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathologic Validation and Diagnostic Accuracy of Presynaptic Dopaminergic Imaging in the Diagnosis of Parkinsonism.
    Hastings A; Cullinane P; Wrigley S; Revesz T; Morris HR; Dickson JC; Jaunmuktane Z; Warner TT; De Pablo-Fernández E
    Neurology; 2024 Jun; 102(11):e209453. PubMed ID: 38759132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
    Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS
    J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine transporter imaging in progressive supranuclear palsy: Severe but nonspecific to subtypes.
    Chen QS; Li XY; Li L; Lu JY; Sun YM; Liu FT; Zuo CT; Wang J
    Acta Neurol Scand; 2022 Sep; 146(3):237-245. PubMed ID: 35611608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FP-CIT- and IBZM-SPECT in Corticobasal Syndrome: Results from a Clinical Follow-Up Study.
    Hammesfahr S; Antke C; Mamlins E; Beu M; Wojtecki L; Ferrea S; Dinkelbach L; Moldovan AS; Schnitzler A; Müller HW; Südmeyer M
    Neurodegener Dis; 2016; 16(5-6):342-7. PubMed ID: 26978429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Antonini A; Benti R; De Notaris R; Tesei S; Zecchinelli A; Sacilotto G; Meucci N; Canesi M; Mariani C; Pezzoli G; Gerundini P
    Neurol Sci; 2003 Oct; 24(3):149-50. PubMed ID: 14598060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrastriatal
    Nicastro N; Fleury V; Broc N; Burkhard PR; Garibotto V
    Parkinsonism Relat Disord; 2020 Sep; 78():38-43. PubMed ID: 32698058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses.
    Badoud S; Van De Ville D; Nicastro N; Garibotto V; Burkhard PR; Haller S
    Neuroimage Clin; 2016; 12():234-40. PubMed ID: 27489771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis.
    Seppi K; Scherfler C; Donnemiller E; Virgolini I; Schocke MF; Goebel G; Mair KJ; Boesch S; Brenneis C; Wenning GK; Poewe W
    Arch Neurol; 2006 Aug; 63(8):1154-60. PubMed ID: 16908744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Extrastriatal
    Joling M; Vriend C; van den Heuvel OA; Raijmakers PGHM; Jones PA; Berendse HW; Booij J
    J Nucl Med; 2017 Jul; 58(7):1117-1123. PubMed ID: 27856628
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation with sympathetic skin response,
    Ozawa M; Morishima R; Shimizu T; Takahashi K
    Neurophysiol Clin; 2024 Jul; 54(4):102956. PubMed ID: 38422587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of combined FP-CIT, IBZM, and MIBG scintigraphy in the differential diagnosis of degenerative parkinsonism: a multidimensional statistical approach.
    Südmeyer M; Antke C; Zizek T; Beu M; Nikolaus S; Wojtecki L; Schnitzler A; Müller HW
    J Nucl Med; 2011 May; 52(5):733-40. PubMed ID: 21498527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease.
    Seppi K; Schocke MF; Donnemiller E; Esterhammer R; Kremser C; Scherfler C; Diem A; Jaschke W; Wenning GK; Poewe W
    Mov Disord; 2004 Dec; 19(12):1438-45. PubMed ID: 15390073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel computer-assisted image analysis of [123I]β-CIT SPECT images improves the diagnostic accuracy of parkinsonian disorders.
    Goebel G; Seppi K; Donnemiller E; Warwitz B; Wenning GK; Virgolini I; Poewe W; Scherfler C
    Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):702-10. PubMed ID: 21174092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ¹²³I-FP-Cit and 123I-IBZM SPECT uptake in a prospective normal material analysed with two different semiquantitative image evaluation tools.
    Jakobson Mo S; Larsson A; Linder J; Birgander R; Edenbrandt L; Stenlund H; Forsgren L; Riklund K
    Nucl Med Commun; 2013 Oct; 34(10):978-89. PubMed ID: 23903558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration.
    Pirker W; Asenbaum S; Bencsits G; Prayer D; Gerschlager W; Deecke L; Brücke T
    Mov Disord; 2000 Nov; 15(6):1158-67. PubMed ID: 11104200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations between cerebrospinal fluid homovanillic acid and dopamine transporter SPECT in degenerative parkinsonian syndromes.
    Goto R; Kurihara M; Kameyama M; Komatsu H; Higashino M; Hatano K; Ihara R; Higashihara M; Nishina Y; Matsubara T; Kanemaru K; Saito Y; Murayama S; Iwata A
    J Neural Transm (Vienna); 2023 Apr; 130(4):513-520. PubMed ID: 36871130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary studies of differential impairments of the dopaminergic system in subtypes of progressive supranuclear palsy.
    Lin WY; Lin KJ; Weng YH; Yen TC; Shen LH; Liao MH; Lu CS
    Nucl Med Commun; 2010 Nov; 31(11):974-80. PubMed ID: 20717064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.